Subjective Experiences of Clozapine Treatment by Patients With Chronic Schizophrenia
- 1 May 2000
- journal article
- Published by American Psychiatric Association Publishing in Psychiatric Services
- Vol. 51 (5) , 666-668
- https://doi.org/10.1176/appi.ps.51.5.666
Abstract
A 37-item survey covering a variety of somatopsychic domains was constructed to explore patients' subjective response to treatment with clozapine. The survey was administered to 130 patients with diagnoses of chronic schizophrenic or schizoaffective disorders who were on a stable clozapine regimen. The majority reported improvement in their level of satisfaction, quality of life, compliance with treatment, thinking, mood, and alertness. Most patients reported worsening in nocturnal salivation, and smaller numbers reported worsening in various gastrointestinal and urinary symptoms and weight gain. This general health survey highlights the patients' positive regard for clozapine, despite adverse bodily experiences. Subjective reports are a useful component of outcome measures of drug treatment.Keywords
This publication has 8 references indexed in Scilit:
- Does Participation in Psychosocial Treatment Augment the Benefit of Clozapine?Archives of General Psychiatry, 1998
- Do Different Subjective Evaluation Criteria Reflect Distinct Constructs?Journal of Nervous & Mental Disease, 1998
- Neuroleptic Dysphoria May be the Missing Link between Schizophrenia and Substance AbuseJournal of Nervous & Mental Disease, 1997
- Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodologyAmerican Journal of Psychiatry, 1997
- SchizophreniaNew England Journal of Medicine, 1996
- Clozapine audit: What do patients and relatives think?Journal of Mental Health, 1996
- Clozapine: Efficacy and SafetySchizophrenia Bulletin, 1995
- Subjective Response to Neuroleptics in SchizophreniaSchizophrenia Bulletin, 1993